Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998

Clinical Infectious Diseases

Volumn 35, Issue 11, 2002, Pages 1376-1381

  Brundage, John F ^a,e   Ryan, Margaret A K ^c   Feighner, Brian H ^b   Erdtmann, Frederick J ^d  

^a Henry Jackson Foundation for Advancement in Military Medicine   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d NATIONAL ACADEMY OF SCIENCES   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; BLOOD GROUP TYPING; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MILITARY SERVICE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SOLDIER; UNITED STATES; VACCINATION;

HOSPITALIZATION; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MILITARY PERSONNEL; NEISSERIA MENINGITIDIS; SEROTYPING; UNITED STATES;

EID: 0036904875     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344273     Document Type: Article

References (30)

1. Brundage JF, Zollinger WD. Evolution of meningococcal disease epidemiology in the US army. In: Vedros NA, ed. Evolution of Meningococcal Disease. Vol 1. Boca Raton, FL: CRC Press, 1987:6-23.
2. Herrick WW. Early diagnosis and intravenous serum treatment of epidemic cerebrospinal meningitis. JAMA 1918; 71:612-7.
3. Cerebrospinal meningitis. In: The Medical Department of the United States Army in the World War. Vol. 9. Communicable Diseases. Washington, DC: US Government Printing Office, 1928.
4. Phair JJ, Schoenbach EB, Root CM. Meningococcal carrier studies. Am J Public Health 1944; 34:148-54.
5. Phair JJ. Meningococcal meningitis. In: Preventive Medicine in World War II. Vol. 4. Communicable Diseases. Washington, DC: Office of the Surgeon General, US Department of the Army, 1958:191-209.
6. Medical Statistics in World War II. Washington, DC: Office of the Surgeon General, US Department of the Army, 1975:407.
7. Sartwell PW, Smith WM. Epidemiological notes on meningococcal meningitis in the Army. Am J Public Health 1944; 34:40-9.
8. Dingle JH, Thomas L, Morton AR. Treatment of meningococcal meningitis with sulfadiazine. JAMA 1941; 116:2666-8.
9. Cheever FS, Breese BB, Upham HC. The treatment of meningococcus carrier with sulfadiazine. Ann Intern Med 1943; 19:602-8.
10. Kuhns DM, Nelson CT, Feldman HA, Kuhn LR. The prophylactic value of sulfadiazine in the control of meningococcic meningitis. JAMA 1943; 123:335-9.
11. Singer RC. Sulfonamide-resistant meningococcal disease. Med Clin North Am 1967; 5:719-27.
12. Millar JW, Siess EE, Feldman HA, Silverman C, Frank P. In vivo and in vitro resistance to sulfadiazine in strains of Neisseria meningitidis. JAMA 1963; 186:2:139-41.
13. Jordan WS. History of the commission on acute respiratory diseases, commission on air-borne infections, commission on meningococcal meningitis, and commission on pneumonia. In: Woodward TE, ed. The Armed Forces Epidemiological Board: The Histories of the Commissions. Washington, DC: Borden Institute, 1994:27.
14. Gauld JR, Nitz RE, Hunter DH, Rust JH, Gauld RL. Epidemiology of meningococcal meningitis at Fort Ord. Am J Epidemiol 1965; 82:56-72.
15. Cataldo JR, Audet HH, Hesson DK, Mandel AD. Sulfadiazine and sulfadiazine-penicillin in mass prophylaxis of meningococcal carriers. Mil Med 1968; 133:453-7.
16. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I-IV. J Exp Med 1969; 129(Suppl 6):1307-67.
17. Gold R, Artenstein MS. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ 1971; 45:279-82.
18. Artenstein MS. Control of meningococcal meningitis with meningococcal vaccines. Yale J Biol Med 1975; 48:197-200.
19. Moore PS. Meningococcal meningitis in sub-Saharan Africa: A model for the epidemic process. Clin Infect Dis 1992; 14:515-25.
20. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA 2001; 286:694-9.
21. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR Morb Mortal Wkly Rep 1993; 42:21-30.
22. Meningococcal meningitis. In: Chin J, Ascher MS, eds. Control of Communicable Diseases, 17th Ed. Washington, DC: American Public Health Association, 2000:340.
23. Harrison LH, Broome CV. The epidemiology of meningococcal meningitis in the US civilian population. In: Vedros NA, ed. Evolution of Meningococcal Disease. Vol 1. Boca Raton, FL: CRC Press, 1987:27-45.
24. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180:1894-1901.
25. Neal KR, Nguyen-Van-Tam J, Monk P, O'Brien SJ, Stuart J, Ramsay M. Invasive meningococcal disease among university undergraduates: Association with universities providing relatively large amounts of catered hall accommodation. Epidemiol Infect 1999; 122:351-7.
26. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. JAMA 1999; 281:1906-10.
27. Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA 2001; 286:688-93.
28. Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health 1995; 85:843-5.
29. Centers for Disease Control and Prevention. Meningococcal disease and meningococcal disease and college students: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49(RR-7):13-20.
30. Wenger J. Toward control of meningococcal disease: Reducing risk in college students. JAMA 2001; 286:720-1.